Microfluidics is a science that flows at the microscopic scale. However, it is also mature technology that has already been applied to everyday technology such as e-readers, inkjet printers, and lab-on-a-chip devices that can shrink a whole laboratory down to a few square inches. Microfluidics can be applied to personalized medicine in addition to everyday technology. Treatment for individuals is adjusted to their specific characteristics through personalized medicine. Based on this biomarkers and drug screening are used for maximizing efficiency and reducing adverse effects. The need for well-regulated, sustainable, and detailed methods is constantly needed to reduce reagent use and improve overall healthcare outcomes. Here we show the development of microfluidic technologies to advance personalized medicine by analyzing microRNAs, and other biomarkers through high-throughput screening, integrating advanced data analytics to match a particular treatment to a patient's unique genetic profile and response.
No takes yet. Share an insight, caveat, or question.
Tripathi et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: